About 2 results
Open links in new tab
Syros Pharmaceuticals Presents Data Demonstrating Significant Anti ...
Syros Pharmaceuticals Presents Data Demonstrating Significant Anti-Cancer Activity of SY-1425 in Preclinical Models of Acute Myeloid Leukemia
Press Releases :: Syros Pharmaceuticals, Inc. (SYRS)
Syros Pharmaceuticals to Present Initial Data from SELECT-AML-1 Phase 2 Trial at 64th ASH Annual Meeting Oct 5, 2022